ArticleInternational journal of oncology2022

TRIB2 regulates the expression of miR‑33a‑5p through the ERK/c‑Fos pathway to affect the imatinib resistance of chronic myeloid leukemia cells.

Hang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.